<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6963560/table_4" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 4</label>
  <p>Treatment of HCV-related glomerular disease according to clinical presentation.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Presentation</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Treatment</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-nephrotic proteinuria</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">DAA-based regimen ( 
    <a rid="pathogens-08-00176-t001" ref-type="table">Table 1</a>) 
    <br/>ACEIs and/or ARBs 
    <br/>Diuretics, anti-hypertensive agents 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stable and mild kidney dysfunction (GFR &gt; 30 mL/min/1.72 m 
    <sup>2</sup>) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nephrotic syndrome</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Rituximab, Plasma-exchange, IV steroids, mycophenolate mofetil 
    <br/>DAA based regimen ( 
    <a rid="pathogens-08-00176-t001" ref-type="table">Table 1</a>) 
    <br/>ACEIs and/or ARBs 
    <br/>Diuretics, anti-hypertensive agents 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryoglobulinemic flare</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rapidly progressive glomerulonephritis</td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>ACEIs = angiotensin-converting enzyme inhibitors; ARBs, angiotensin-receptor blockers; DAAs = direct-acting antiviral agents; GFR = glomerular filtration rate; iv = intravenous.</p>
  </p>
 </tfoot>
</table>
